Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Economou

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Cancer|June 1, 1977
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)B Fisher, A Glass, C Redmond, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanomaLisa H Butterfield, Begonya Comin-Anduix, Lazar Vujanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockadeAntoni Ribas, Begoña Comin-Anduix, James S Economou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.
Cancer Research|December 5, 2000
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cellsK J Andrews, A Ribas, L H Butterfield, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cellsFrancesca Giannoni, Cinnamon L Hardee, Jennifer Wherley, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Broad antitumor protection by dendritic cells administered to CD8alpha knock out miceAntoni Ribas, Dan D Vo, David L Weeks, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapyAntoni Ribas, John A Glaspy, Yohan Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptidesLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Cancer|June 1, 1977
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)B Fisher, A Glass, C Redmond, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanomaLisa H Butterfield, Begonya Comin-Anduix, Lazar Vujanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockadeAntoni Ribas, Begoña Comin-Anduix, James S Economou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.
Cancer Research|December 5, 2000
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cellsK J Andrews, A Ribas, L H Butterfield, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cellsFrancesca Giannoni, Cinnamon L Hardee, Jennifer Wherley, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Broad antitumor protection by dendritic cells administered to CD8alpha knock out miceAntoni Ribas, Dan D Vo, David L Weeks, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapyAntoni Ribas, John A Glaspy, Yohan Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptidesLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Pageof 16